FDA cracks down on telehealth GLP‑1 compounding claims
Posted by kyle137 in Weight Loss & Metabolic - 2 points, 0 comments.
the Reuters piece reports that the FDA sent 25 warning letters to telehealth companies for making false or misleading claims about compounded GLP‑1 weight‑loss drugs like semaglutide and tirzepatide. they’re basically telling those outfits to stop marketing “miracle” results without proper data.
i’m kinda skeptical of the whole telehealth hype because most of the “clinical” outcomes they brag about are just anecdotal testimonials. in my own experiments, i’ve seen decent weight loss with a low‑dose semaglutide protocol, but only after careful titration and bloodwork. the article didn’t mention that a lot of these compounded products can vary in potency, which can mess with dosing consistency and side‑effects. also, the FDA warning highlights the need for proper medical oversight, something i always stress before starting any GLP‑1.
has anyone here run into quality issues with compounded GLP‑1s, or stick to brand‑name prescriptions only? what’s your take on the risk‑vs‑benefit of using these telehealth services? 👀
Community discussion - research and educational context only. Not medical advice.